Optoseeker Biotech and BioMap Collaborate to Accelerate Antibody Therapeutics Development
Optoseeker Biotech, a leader in advanced life science instrumentation, and BioMap, a pioneer in life...
AI
Royal Philips and Suzhou Peixin Collaborate on AI-Powered Interventional Therapy Platform for Structural Heart Disease
Dutch device giant Royal Philips (NYSE: PHG) and China-based Suzhou Peixin Technology Co., Ltd. late...
Roche’s Chugai Pharmaceutical Partners with Gero to Develop Therapies for Age-Related Diseases
Roche’s Japan-based subsidiary Chugai Pharmaceutical Co., Ltd. (TYO: 4519) announced this week a joint research...
Modella AI Collaborates with AstraZeneca to Accelerate Oncology Drug Development with AI
US-based Modella AI, a leader in biomedical artificial intelligence (AI), announced a multi-year collaboration with...
China’s WeiMai Plans Hong Kong IPO to Expand AI-Powered Healthcare Services
China-based WeiMai Inc. plans to make an initial public offering (IPO) to the Hong Kong...
Kanion Pharma and Space Peptides Submit IND for AI-Enabled CCR8 Peptide Inhibitor KYS2301
Chinese partners Jiangsu Kanion Pharmaceutical Co., Ltd (SHA: 600557) and Space Peptides jointly announced the...
XtalPi Completes Pre-Seed Investment in Foundry BioSciences to Advance AI-Driven Longevity Therapeutics
Shenzhen-based QuantumPharm Inc. (HKG: 2228), also known as Xtalpi Inc., announced the completion of a...
Hybio and iCarbonX Enter CRDMO Service Pact and Strategic Investment to Advance Peptide Drug Pipeline
This week, China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) and iCarbonX entered into an innovative...
QuantumPharm and Pfizer Expand Collaboration on Advanced Molecular Simulation Platform
Shenzhen-based QuantumPharm Inc., known as Xtalpi Inc. (HKG: 2228), has announced an expansion of its...
Diagens Biotech’s AI Imaging Platform iMedImage Makes Hong Kong IPO Debut
China-based Hangzhou Diagens Biotechnology Co., Ltd. has filed for an initial public offering (IPO) with...
XtalPi Signs LOI With DoveTree for AI-Powered Drug Development
Shenzhen-based QuantumPharm Inc., known as Xtalpi Inc. (HKG: 2228), announced the signing of a Letter...
Insilico Medicine Partners with UAEU to Drive Biotech Innovation in the Middle East
China-based generative artificial intelligence (AI)-driven biotech Insilico Medicine this week entered into a strategic Memorandum...
United Imaging Intelligence Closes RMB 1B Series A Round to Boost AI in Healthcare
United Imaging Intelligence, the AI-focused subsidiary of Shanghai United Imaging Healthcare Co., Ltd., reportedly secured...
FDA Launches ‘Elsa’ AI Tool to Enhance Staff Efficiency in Regulatory Processes
The U.S. Food and Drug Administration (FDA) announced the launch of an artificial intelligence (AI)...
NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery
US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo...
Kindstar Global Partners with Biostate AI to Advance Precision Medicine
China-based Kindstar Global (HKG: 9960) announced the establishment of a joint venture (JV) with US-headquartered...
Consun Pharma Partners with DP Technology to Accelerate AI-Driven Kidney Disease Drug R&D
China-based Consun Pharmaceutical Group Ltd (HKG: 1681) announced a strategic partnership with compatriot firm DP...
Shanghai Ark Bio and Partex Collaborate on ATR Inhibitor AK0658 Development
China’s Shanghai Ark Biopharmaceutical Co., Ltd. has entered into a new cooperation agreement with Germany-based...
Danaher Partners with AstraZeneca to Advance Precision Medicine
US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced a strategic partnership with...
Shandong Boan Biotechnology Partners with HKUST for Biomedicine Innovation
China-based Shandong Boan Biotechnology Co., Ltd (HKG: 6955) has entered into a partnership with the...